col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


89 Results       Page 1

 [1] 
Georg Thieme Verlag KG: Seminars in Thrombosis and Hemostasis
  original article Date Title Authors   All Authors
1 [GO] 2023―Nov―20 Recommendations on the use of COVID-19 Convalescent Plasma to Treat Immunocompromised Patients Massimo Franchini, Arturo Casadevall, Jonathon W. Senefeld, Michael J. Joyner, David J. Sullivan, Daniele Focosi
2 [GO] 2023―Sep―27 Congenital Bleeding Disorders and COVID-19-A Systematic Literature Review Akbar Dorgalaleh, Seyed Mehrab Safdari, Shadi Tabibian, Mahmood Shams, Ali Dabbagh, Azadeh Rezazadeh
3 [GO] 2023―Sep―25 Post COVID-19 Large Vessel Vasculopathy in a Previously Healthy Young Male Bingwen Eugene Fan, Shravan Sadasiv Mucheli, Yee Lin Tang, Enming Yong, Rinkoo Dalan, Christine Cheung, et al. (+13)
4 [GO] 2023―Jun―24 D-dimer in Coronavirus 2019: An Acute Phase Reactant? Claudia Minutti-Zanella, Moisés M. Gallardo-Pérez, Guillermo J. Ruiz-Argüelles
5 [GO] 2023―Jun―16 Effects of Recombinant SARS-CoV-2 Spike Protein Variants on Platelet Morphology and Activation Marco Vettori, Giovanni Carpenè, Gian Luca Salvagno, Matteo Gelati, Francesco Dima, Giovanni Celegon, et al. (+2)
6 [GO] 2023―Mar―20 The Post-Venous Thromboembolism Functional Status Scale: From Call to Action to Application in Research, Extension to COVID-19 Patients, and Its Use in Clinical Practice Cindy M. M. de Jong, Gudula J.A.M. Boon, Y. N. Jenny Le, Stefano Barco, Bob Siegerink, Frederikus A. Klok
7 [GO] 2023―Feb―21 Association between Severe Acute Respiratory Syndrome Coronavirus 2Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment Marta Monti, Tiziano Martini, Vittorio Pengo, Giovanni Poletti, Paola Pedrazzi, Chiara Biasoli, et al. (+2)
8 [GO] 2023―Feb―14 Increased Platelet Activation demonstrated by Elevated CD36 and P-Selectin Expression in 1-Year Post-Recovered COVID-19 Patients Samuel Sherng Young Wang, Keefe Chee, Shiun Woei Wong, Guat Bee Tan, Hong Ang, Bernard PuiLam Leung, et al. (+9)
9 [GO] 2023―Jan―24 Has “D-Dimeritis” Worsened during the Coronavirus Disease 2019 Pandemic? Giuseppe Lippi, Valeria Perilli
10 [GO] 2023―Jan―05 Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part IV Emmanuel J. Favaloro, Leonardo Pasalic, Giuseppe Lippi
11 [GO] 2023―Jan―05 COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications Ali Zidan, Abdelrahman Noureldin, Shreya Anil Kumar, Abdelrahman Elsebaie, Maha Othman
12 [GO] 2022―Nov―06 “True” Antiphospholipid Syndrome in COVID-19: Contribution of the Follow-up of Antiphospholipid Autoantibodies Robin Arcani, Raphaël Cauchois, Pierre Suchon, Samuel Weber, Rodolphe Jean, Pierre-André Jarrot, et al. (+8)
13 [GO] 2022―Oct―12 COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment Luis Ortega-Paz, Azita H. Talasaz, Parham Sadeghipour, Tatjana S. Potpara, Herbert D. Aronow, Luis Jara-Palomares, et al. (+4)
14 [GO] 2022―Sep―29 Low-Molecular-Weight Heparin Resistance and Its Viscoelastic Assessment in Critically Ill COVID-19 Patients Johannes Bösch, Christopher Rugg, Volker Schäfer, Philipp Lichtenberger, Nikolai Staier, Benjamin Treichl, et al. (+5)
15 [GO] 2022―Sep―29 The Case for Therapeutic-Intensity Anticoagulation in Patients with COVID-19-Associated Moderate Illness Adam Cuker
16 [GO] 2022―Sep―29 Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Severity of Clinical Illness Lize M. Grobbelaar, Arneaux Kruger, Chantelle Venter, Este M. Burger, Gert J. Laubscher, Tongai G. Maponga, et al. (+16)
17 [GO] 2022―Sep―02 Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus? Giuseppe Lippi, Emmanuel J. Favaloro
18 [GO] 2022―Sep―02 Against Therapeutic Anticoagulation in Critically Ill COVID-19 Patients John G. Rizk, Carl J. Lavie, Brandon Michael Henry
19 [GO] 2022―Sep―02 Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review Massimo Franchini, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, Ugo Moretti, Daniele Focosi, Marco Tuccori
20 [GO] 2022―Jul―08 D-dimers-“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19 Jecko Thachil, Emmanuel J. Favaloro, Giuseppe Lippi
21 [GO] 2022―Jul―06 Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis Matteo Candeloro, Sam Schulman
22 [GO] 2022―Jun―27 Acquired Thrombotic Thrombocytopenic Purpura: A Rare Coincidence after COVID-19 mRNA Vaccine? Allison C. Y. Tso, Kiat H. Ong, Christina L. L. Sum, Bingwen E. Fan, Grace Y. L. Chan, Dheepa Christopher, et al. (+4)
23 [GO] 2022―Jun―23 Platelet Activation and Thrombosis in COVID-19 Toshiaki Iba, Hideo Wada, Jerrold H. Levy
24 [GO] 2022―Jun―23 Proposal for a Simple Algorithmic Approach to Manage Drug-Drug Interactions of Oral Anticoagulants with Nirmatrelvir/Ritonavir in COVID-19 Outpatients John G. Rizk, Jose G. Lazo, Aashish Gupta, Carl J. Lavie, Mark B. Effron
25 [GO] 2022―Jun―21 Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Response to Comment Domenico Benvenuto, Sergio Carnevale, Marta Giovanetti, Massimo Ciccozzi, Francesco Broccolo
26 [GO] 2022―Apr―25 To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years John G. Rizk, Aashish Gupta, Jose G. Lazo, Partha Sardar, Brandon Michael Henry, Carl J. Lavie, Mark B. Effron
27 [GO] 2022―Apr―22 Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Comment Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
28 [GO] 2022―Mar―08 Aspirin use Reduces Platelet Hyperreactivity and Degranulation in COVID-19 Patients Younes Zaid, Qamar Lahlimi, Loubna Khalki, Nabil Zaid, Mounia Oudghiri, Amine Cheikh, et al. (+3)
29 [GO] 2022―Feb―15 The Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties Giuseppe Lippi, Brandon M. Henry, Emmanuel J. Favaloro
30 [GO] 2022―Feb―01 Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part III Emmanuel J. Favaloro, Giuseppe Lippi
31 [GO] 2022―Jan―12 What We Know (and Do not Know) Regarding the Pathogenesis of Pulmonary Thrombosis in COVID-19 Giuseppe Lippi, Emmanuel J. Favaloro
32 [GO] 2022―Jan―12 Is Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein a Potential Basis for Autoimmune Responses in Vaccinated and Naturally Infected Patients? Sergio Carnevale, Marta Giovanetti, Domenico Benvenuto, Massimo Ciccozzi, Francesco Broccolo
33 [GO] 2021―Dec―14 Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings Giacomo Buso, Lucia Mazzolai, José Antonio Rueda-Camino, Carmen Fernández-Capitán, David Jiménez, Behnood Bikdeli, et al. (+4)
34 [GO] 2021―Oct―29 Dynamic Hemostasis and Fibrinolysis Assays in Intensive Care COVID-19 Patients and Association with Thrombosis and Bleeding-A Systematic Review and a Cohort Study Christine Lodberg Hvas, Julie Brogaard Larsen, Kasper Adelborg, Steffen Christensen, Anne-Mette Hvas
35 [GO] 2021―Oct―25 The Impact of SARS-CoV-2 Infection on Blood Coagulation and Fibrinolytic Pathways: A Review of Prothrombotic Changes Caused by COVID-19 Mehran Bahraini, Akbar Dorgalaleh
36 [GO] 2021―Oct―25 Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More Giuseppe Lippi, Emmanuel J. Favaloro
37 [GO] 2021―Oct―10 COVID-19 Vaccine-Induced Immune Thrombosis with Thrombocytopenia (VITT) and the Shades of Grey in Thrombus Formation Jecko Thachil
38 [GO] 2021―Sep―24 Acquired Factor V Inhibitor after Coronavirus Disease 2019 (COVID-19) Federico Chiurazzi, Antonella Tufano, Maria Esposito, Francesco D'Agostino, Aniello Casoria, Filomena Capasso, Giovanni Di Minno
39 [GO] 2021―Aug―13 Involvement of Inflammation in Venous Thromboembolic Disease: An Update in the Age of COVID-19 Peter Poredos, Pavel Poredos
40 [GO] 2021―Aug―13 Impact of Thrombosis and Bleeding in Patients with Severe COVID-19 versus Other Viral Pneumonias in the Context of Extracorporeal Membrane Oxygenation Anna Weatherill, Mike Laffan, Mihaela Gasper, Paolo Bianchi, Maurizio Passariello, Suveer Singh, et al. (+5)
41 [GO] 2021―Aug―13 Spontaneous Muscle Hematoma in Patients with COVID-19: A Systematic Literature Review with Description of an Additional Case Series Veronica Abate, Aniello Casoria, Ferruccio Galletti, Giovanni Di Minno, Domenico Rendina, Riccardo Muscariello, et al. (+6)
42 [GO] 2021―Jun―15 COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check? Emmanuel J. Favaloro, Brandon Michael Henry, Giuseppe Lippi
43 [GO] 2021―Jun―15 Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature Emmanuel J. Favaloro, Brandon Michael Henry, Giuseppe Lippi
44 [GO] 2021―Jun―01 Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II Emmanuel J. Favaloro, Giuseppe Lippi
45 [GO] 2021―May―10 Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation Youness Limami, Loubna Khalki, Nabil Zaid, Meriem Khyatti, Joumana El Turk, Mounia Ammara, et al. (+5)
46 [GO] 2021―May―07 Sustained High D-Dimer in Outpatients Who Have Recovered from Mild to Moderate Coronavirus Disease 2019 (COVID-19) Serafino Fazio, Antonella Tufano, Giovanni de Simone
47 [GO] 2021―Apr―24 Mean Platelet Volume Predicts Severe COVID-19 Illness Giuseppe Lippi, Brandon M. Henry, Emmanuel J. Favaloro
48 [GO] 2021―Apr―24 Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization Matthias M. Engelen, Christophe Vandenbriele, Tim Balthazar, Eveline Claeys, Jan Gunst, Ipek Guler, et al. (+15)
49 [GO] 2021―Apr―24 Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis Emmanuel J. Favaloro, Brandon Michael Henry, Giuseppe Lippi
50 [GO] 2021―Apr―16 Post COVID-19 Arterial Thromboembolism: A Clear and Present Danger Bingwen Eugene Fan, Christine Cheung
51 [GO] 2021―Apr―14 Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis Roberta Parisi, Simona Costanzo, Augusto Di Castelnuovo, Giovanni de Gaetano, Maria Benedetta Donati, Licia Iacoviello
52 [GO] 2021―Apr―14 Platelet Function in Viral Immunity and SARS-CoV-2 Infection Afaf Allaoui, Akif A. Khawaja, Oussama Badad, Mariam Naciri, Marie Lordkipanidzé, Fadila Guessous, Younes Zaid
53 [GO] 2021―Feb―20 Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage John E. Stillson, Connor M. Bunch, Laura Gillespie, Rashid Khan, Meredith Wierman, Joseph Pulvirenti, et al. (+8)
54 [GO] 2021―Jan―23 Efficacy Safety and of D-dimer, Weight, and Renal Function-Adjusted Thromboprophylaxis in Patients with Coronavirus Disease 2019 (COVID-19) Abdul A. Shlebak, Mike Laffan, Deepa R. J. Arachchillage, Christine Shi, David Saliu, Peter Kozman, et al. (+7)
55 [GO] 2021―Jan―23 Does COVID-19 Provide a Clue for Thrombosis in ITP? Jecko Thachil
56 [GO] 2021―Jan―23 Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-analysis Mairi Pucci, Diletta Onorato, Giovanni Carpene, Brandon Michael Henry, Fabian Sanchis-Gomar, Giuseppe Lippi
57 [GO] 2021―Jan―23 Thrombin Generation in Patients with Coronavirus Disease 2019 Marco Benati, Gian Luca Salvagno, Simone De Nitto, Matteo Gelati, Barbara Lavorgna, Cristiano Fava, et al. (+2)
58 [GO] 2021―Jan―23 Circulating Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Independent Predictors of Coronavirus Disease 2019 Severity: A Prospective, Observational Study Brandon Michael Henry, Isaac Cheruiyot, Justin L. Benoit, Giuseppe Lippi, Zoltán Prohászka, Emmanuel J. Favaloro, Stefanie W. Benoit
59 [GO] 2021―Jan―12 Relevance of Heparan Sulfate and Heparanase to Severity of COVID-19 in the Elderly Yona Nadir, Benjamin Brenner
60 [GO] 2020―Dec―31 Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness Giuseppe Lippi, Brandon M. Henry, Fabian Sanchis-Gomar
61 [GO] 2020―Dec―31 Pulmonary Thrombosis in COVID-19 Treated by Thrombolysis: A Small Case Series Using Streptokinase Armando Caballero López, Carlos Herrera Cartaya, Elibet Chávez González, Delvis González Reinoso, Jorge Alain Caballero Font, Naivi Sánchez Vera, et al. (+5)
62 [GO] 2020―Dec―18 Fatal Disseminated Intravascular Coagulopathy in Covid-19: A Small Case Series Samia Kazmi, Fivzia Herekar, Samreen Sarfaraz
63 [GO] 2020―Oct―21 Presenting Characteristics, Treatment Patterns, and Outcomes among Patients with Venous Thromboembolism during Hospitalization for COVID-19 Carmen Fernández-Capitán, Raquel Barba, María del Carmen Díaz-Pedroche, Patricia Sigüenza, Pablo Demelo-Rodriguez, Carmine Siniscalchi, et al. (+14)
64 [GO] 2020―Oct―20 Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part I Emmanuel J. Favaloro, Giuseppe Lippi
65 [GO] 2020―Sep―04 Catheter-Directed Thrombolysis in a Patient with Severe COVID-19 Pneumonia on Extracorporeal Membrane Oxygenation Guy J. Padley, Shivani S. Desai, Chrissy Weaver, Laura C. Price, Deepa J. Arachchillage, Carole A. Ridge
66 [GO] 2020―Sep―03 Perspectives on Platelet Heterogeneity and Host Immune Response in Coronavirus Disease 2019 (COVID-19) Iván Parra-Izquierdo, Joseph E. Aslan
67 [GO] 2020―Sep―03 Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19) Brandon Michael Henry, Stefanie W. Benoit, Jonathan Hoehn, Giuseppe Lippi, Emmanuel J. Favaloro, Justin L. Benoit
68 [GO] 2020―Sep―03 Pulmonary Megakaryocytes in Coronavirus Disease 2019 (COVID-19): Roles in Thrombi and Fibrosis Jecko Thachil, Ton Lisman
69 [GO] 2020―Sep―03 Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)? Job Harenberg, Rupert Bauersachs, Walter Ageno
70 [GO] 2020―Sep―03 COVID-19 and Sex-/Gender-Specific Differences: Understanding the Discrimination Ariunzaya Amgalan, Ann Kinga Malinowski, Maha Othman
71 [GO] 2020―Sep―03 COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies Alessandro Di Minno, Pasquale Ambrosino, Ilenia Calcaterra, Matteo Nicola Dario Di Minno
72 [GO] 2020―Sep―03 Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes Emma Kate Zadow, Daniel William Taylor Wundersitz, Diane Louise Hughes, Murray John Adams, Michael Ian Charles Kingsley, Hilary Anne Blacklock, et al. (+4)
73 [GO] 2020―Sep―02 Atypical Spontaneous Hematomas in a Patient with Severe Coronavirus Disease 2019 (COVID-19) Devis Benfaremo, Elisa Fustini, Silvia Gennarini, Massimo Mattioli
74 [GO] 2020―Sep―02 Hematology Laboratory Abnormalities in Patients with Coronavirus Disease 2019 (COVID-19) Bianca Christensen, Emmanuel J. Favaloro, Giuseppe Lippi, Elizabeth M. Van Cott
75 [GO] 2020―Sep―02 Immune-Mediated Coagulopathy in COVID-19 Infection Zahava Vadasz, Benjamin Brenner, Elias Toubi
76 [GO] 2020―Aug―21 Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19 Ashkan Hashemi, Mahesh V. Madhavan, Behnood Bikdeli
77 [GO] 2020―Aug―12 Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19 Netanel A. Horowitz, Benjamin Brenner
78 [GO] 2020―Jun―18 Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)? Akbar Dorgalaleh, Ali Dabbagh, Shadi Tabibian, Mohammad Reza Baghaeipour, Mohammad Jazebi, Mehran Bahraini, et al. (+3)
79 [GO] 2020―Jun―11 Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection Steven de Maat, Quirijn de Mast, A.H. Jan Danser, Frank L. van de Veerdonk, Coen Maas
80 [GO] 2020―Jun―11 Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma Paul F. Lindholm, Glenn Ramsey, Hau C. Kwaan
81 [GO] 2020―Jun―08 Bleeding and Bleeding Risk in COVID-19 Akbar Dorgalaleh
82 [GO] 2020―Jun―08 Challenges in the Production of Convalescent Hyperimmune Plasma in the Age of COVID-19 Massimo Franchini, Claudia Del Fante, Catherine Klersy, Claudia Glingani, Elena Percivalle, Fausto Baldanti, Cesare Perotti
83 [GO] 2020―Jun―08 Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders Antonio Coppola, Annarita Tagliaferri, Gianna Franca Rivolta, Gabriele Quintavalle, Massimo Franchini
84 [GO] 2020―Jun―08 Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy-Either, Neither, or Both Marcel Levi, Jecko Thachil
85 [GO] 2020―May―12 SARS-2 Coronavirus-Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism? Jecko Thachil, Alok Srivastava
86 [GO] 2020―May―11 Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism Sam Schulman
87 [GO] 2020―May―09 Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae Hau C. Kwaan
88 [GO] 2020―May―01 Platelets in Coronavirus Disease 2019 Julie Brogaard Larsen, Leonardo Pasalic, Anne-Mette Hvas
89 [GO] 2020―Apr―12 Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring Emmanuel J. Favaloro, Giuseppe Lippi
 [1] 

89 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.009 sec